Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
  • inderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement

Cell Impact
Ladda ner börsmeddelandet

Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen. The agreement includes a shared ambition to carry out joint marketing activities as well as technical development of flow plates and manufacturing processes for fuel cells and electrolyzers.

thyssenkrupp Automation Engineering is a business unit of the automotive segment of the industrial group thyssenkrupp. With a focus on drive and battery assembly systems - particularly for electric mobility - the company offers high-quality, innovative automation solutions for series production. Around 1,100 employees work for Automation Engineering across ten countries on three continents.

"They have extensive experience in automation and industrialization, and are simply a highly suitable partner for us. Based on Cell Impact Forming™, our unique and patented forming technology, we can scale the business together with thyssenkrupp by developing, marketing, and supplying cost-effective and high-quality flow plates to customers worldwide," says Daniel Vallin, CEO of Cell Impact.

During several years, Cell Impact has been developing forming technology and other process steps to enable industrial-scale production of flow plates once market demand is established.

 The company has already manufactured and delivered several million flow plates to customers in Asia, North America, and Europe.

The cooperation agreement builds on a Letter of Intent (LOI) that the parties agreed upon in July 2025.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.